Home Pharmaceuticals Hikma Pharmaceuticals

Hikma Pharmaceuticals

Random

Hikma and Almirall enter an exclusive licensing agreement to market FinjuveTM in the Middle East and North Africa region

November 2, 2021

Hikma and Winterlight Labs PoC Collaboration

Hikma delivers another year of profitable growth in 2021 and announces share buyback

Hikma continues strong strategic execution and reiterates guidance

Hikma and Adalvo Sign Exclusive Licensing Agreement to Commercialise Allergic Rhinitis Medication across MENA Markets

Hikma delivers another strong financial and operational performance, and improves FY...

August 8, 2021

Hikma and Winterlight Labs PoC Collaboration

November 23, 2021

Hikma Ventures Participates in USD 44 Million Financing Round for Altibbi...

March 30, 2022

Hikma acquires the rights to a portfolio of Takeda brands for...

December 20, 2024

Hikma’s diversified business delivers resilient H1 performance

August 4, 2022

Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel...

April 29, 2021

Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition

April 30, 2022

Hikma continues strong strategic execution and reiterates guidance

November 7, 2024

Hikma strengthens US Injectables business through acquisition of Custopharm

September 29, 2021

Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma®...

January 4, 2023

12 Page 1 of 2